300 related articles for article (PubMed ID: 18498120)
21. CDX2 co-localizes with liver-intestine cadherin in intestinal metaplasia and adenocarcinoma of the stomach.
Ko S; Chu KM; Luk JM; Wong BW; Yuen ST; Leung SY; Wong J
J Pathol; 2005 Apr; 205(5):615-22. PubMed ID: 15732140
[TBL] [Abstract][Full Text] [Related]
22. Bone morphogenetic protein 2 is expressed by, and acts upon, mature epithelial cells in the colon.
Hardwick JC; Van Den Brink GR; Bleuming SA; Ballester I; Van Den Brande JM; Keller JJ; Offerhaus GJ; Van Deventer SJ; Peppelenbosch MP
Gastroenterology; 2004 Jan; 126(1):111-21. PubMed ID: 14699493
[TBL] [Abstract][Full Text] [Related]
23. SOX2 Inhibition Promotes Promoter Demethylation of CDX2 to Facilitate Gastric Intestinal Metaplasia.
Niu H; Jia Y; Li T; Su B
Dig Dis Sci; 2017 Jan; 62(1):124-132. PubMed ID: 27913994
[TBL] [Abstract][Full Text] [Related]
24. Glypican-3 modulates inhibitory Bmp2-Smad signaling to control renal development in vivo.
Hartwig S; Hu MC; Cella C; Piscione T; Filmus J; Rosenblum ND
Mech Dev; 2005 Jul; 122(7-8):928-38. PubMed ID: 15925496
[TBL] [Abstract][Full Text] [Related]
25. Shigella dysenteriae modulates BMP pathway to induce mucin gene expression in vivo and in vitro.
Gopal A; Iyer SC; Gopal U; Devaraj N; Halagowder D
PLoS One; 2014; 9(11):e111408. PubMed ID: 25365201
[TBL] [Abstract][Full Text] [Related]
26. Expression of Cdx1 and Cdx2 mRNAs and relevance of this expression to differentiation in human gastrointestinal mucosa--with special emphasis on participation in intestinal metaplasia of the human stomach.
Mizoshita T; Inada K; Tsukamoto T; Kodera Y; Yamamura Y; Hirai T; Kato T; Joh T; Itoh M; Tatematsu M
Gastric Cancer; 2001; 4(4):185-91. PubMed ID: 11846061
[TBL] [Abstract][Full Text] [Related]
27. Ectopic expression of homeodomain protein CDX2 in intestinal metaplasia and carcinomas of the stomach.
Bai YQ; Yamamoto H; Akiyama Y; Tanaka H; Takizawa T; Koike M; Kenji Yagi O; Saitoh K; Takeshita K; Iwai T; Yuasa Y
Cancer Lett; 2002 Feb; 176(1):47-55. PubMed ID: 11790453
[TBL] [Abstract][Full Text] [Related]
28. MiR-9 downregulates CDX2 expression in gastric cancer cells.
Rotkrua P; Akiyama Y; Hashimoto Y; Otsubo T; Yuasa Y
Int J Cancer; 2011 Dec; 129(11):2611-20. PubMed ID: 21225631
[TBL] [Abstract][Full Text] [Related]
29. The bone morphogenetic protein pathway is inactivated in the majority of sporadic colorectal cancers.
Kodach LL; Wiercinska E; de Miranda NF; Bleuming SA; Musler AR; Peppelenbosch MP; Dekker E; van den Brink GR; van Noesel CJ; Morreau H; Hommes DW; Ten Dijke P; Offerhaus GJ; Hardwick JC
Gastroenterology; 2008 May; 134(5):1332-41. PubMed ID: 18471510
[TBL] [Abstract][Full Text] [Related]
30. Differentiation reprogramming in gastric intestinal metaplasia and dysplasia: role of SOX2 and CDX2.
Camilo V; Garrido M; Valente P; Ricardo S; Amaral AL; Barros R; Chaves P; Carneiro F; David L; Almeida R
Histopathology; 2015 Feb; 66(3):343-50. PubMed ID: 25196071
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of caudal type homeobox transcription factor 2 inhibits the growth of the MGC-803 human gastric cancer cell line in vivo.
Wei W; Li L; Wang X; Yan L; Cao W; Zhan Z; Zhang X; Yu H; Xie Y; Xiao Q
Mol Med Rep; 2015 Jul; 12(1):905-12. PubMed ID: 25738600
[TBL] [Abstract][Full Text] [Related]
32. Celecoxib inhibits Cdx2 expression and prevents gastric cancer in Helicobacter pylori-infected Mongolian gerbils.
Futagami S; Suzuki K; Hiratsuka T; Shindo T; Hamamoto T; Tatsuguchi A; Ueki N; Shinji Y; Kusunoki M; Wada K; Miyake K; Gudis K; Tsukui T; Sakamoto C
Digestion; 2006; 74(3-4):187-98. PubMed ID: 17341852
[TBL] [Abstract][Full Text] [Related]
33. Expression and localisation of insulin receptor substrate 2 in normal intestine and colorectal tumours. Regulation by intestine-specific transcription factor CDX2.
Modica S; Morgano A; Salvatore L; Petruzzelli M; Vanier MT; Valanzano R; Esposito DL; Palasciano G; Duluc I; Freund JN; Mariani-Costantini R; Moschetta A
Gut; 2009 Sep; 58(9):1250-9. PubMed ID: 19221108
[TBL] [Abstract][Full Text] [Related]
34. Protein associated with SMAD1 (PAWS1/FAM83G) is a substrate for type I bone morphogenetic protein receptors and modulates bone morphogenetic protein signalling.
Vogt J; Dingwell KS; Herhaus L; Gourlay R; Macartney T; Campbell D; Smith JC; Sapkota GP
Open Biol; 2014 Feb; 4(2):130210. PubMed ID: 24554596
[TBL] [Abstract][Full Text] [Related]
35. Expression of bone morphogenetic protein2 (BMP2), BMP4 and BMP receptors in the bovine ovary but absence of effects of BMP2 and BMP4 during IVM on bovine oocyte nuclear maturation and subsequent embryo development.
Fatehi AN; van den Hurk R; Colenbrander B; Daemen AJ; van Tol HT; Monteiro RM; Roelen BA; Bevers MM
Theriogenology; 2005 Feb; 63(3):872-89. PubMed ID: 15629804
[TBL] [Abstract][Full Text] [Related]
36. Expression of Claudin-2 in intestinal metaplastic mucosa of Cdx2-transgenic mouse stomach.
Sakamoto H; Mutoh H; Sugano K
Scand J Gastroenterol; 2010 Nov; 45(11):1273-80. PubMed ID: 20602571
[TBL] [Abstract][Full Text] [Related]
37. HpSlyD inducing CDX2 and VIL1 expression mediated through TCTP protein may contribute to intestinal metaplasia in the stomach.
Li Q; Zhu Y; Liu J; Yu X; Chen M; Dong N; Gong Y; Yuan Y
Sci Rep; 2017 May; 7(1):2278. PubMed ID: 28536478
[TBL] [Abstract][Full Text] [Related]
38. Effects of the hippo signaling pathway in human gastric cancer.
Zhou GX; Li XY; Zhang Q; Zhao K; Zhang CP; Xue CH; Yang K; Tian ZB
Asian Pac J Cancer Prev; 2013; 14(9):5199-205. PubMed ID: 24175801
[TBL] [Abstract][Full Text] [Related]
39. The effect of statins in colorectal cancer is mediated through the bone morphogenetic protein pathway.
Kodach LL; Bleuming SA; Peppelenbosch MP; Hommes DW; van den Brink GR; Hardwick JC
Gastroenterology; 2007 Oct; 133(4):1272-81. PubMed ID: 17919499
[TBL] [Abstract][Full Text] [Related]
40. Helicobacter pylori-induced atrophic gastritis progressing to gastric cancer exhibits sonic hedgehog loss and aberrant CDX2 expression.
Shiotani A; Iishi H; Uedo N; Ishihara R; Ishiguro S; Tatsuta M; Nakae Y; Kumamoto M; Hinoi T; Merchant JL
Aliment Pharmacol Ther; 2006 Dec; 24 Suppl 4():71-80. PubMed ID: 17209848
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
